Does an intrauterine device (IUD) affect the accuracy of serum testosterone testing?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 19, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

IUD Does Not Affect Testosterone Testing Accuracy

An intrauterine device (IUD) does not interfere with the accuracy of serum testosterone testing itself, but levonorgestrel-releasing IUDs can alter sex hormone-binding globulin (SHBG) levels, which may affect the interpretation of testosterone results.

Understanding the Mechanism

The key issue is not test accuracy but rather the physiological changes that occur with hormonal IUDs:

Levonorgestrel-Releasing IUDs (LNG-IUS)

  • SHBG levels may decrease during use of levonorgestrel-containing IUDs, though this effect appears modest and inconsistent 1, 2
  • Research shows that in women with normal body mass index, SHBG concentrations decreased slightly during oral levonorgestrel contraception but not significantly during LNG-IUS use 1
  • One study found mean SHBG levels were lower after LNG-IUD insertion (41.82 nmol/L) compared to pretreatment (62.09 nmol/L), though this difference was not statistically significant 2
  • Total testosterone levels themselves remain unchanged with LNG-IUD use 1, 3

Copper IUDs

  • No effect on testosterone or SHBG levels 4
  • Copper IUDs showed no significant differences in mean testosterone levels compared to controls in both mid-follicular and mid-luteal phases 4

Clinical Implications for Testing

When measuring testosterone in IUD users:

For accurate assessment:

  • Measure testosterone in the morning (7:00-10:00 AM) in the fasting state using a reliable laboratory assay 5, 6
  • The automated assays available in most hospital laboratories are often not suitable to accurately measure testosterone in women 5
  • Use specialty laboratories with validated assays or tandem mass spectrometry methods for accurate androgen determinations 5

When to measure SHBG and calculate free testosterone:

  • In women with LNG-IUS, consider measuring SHBG and calculating free testosterone if clinical suspicion for androgen excess exists 5, 6
  • Free testosterone is more sensitive than total testosterone in detecting excess androgen production, particularly when SHBG is altered 5
  • Calculate free testosterone using the Vermeulen formula based on total testosterone and SHBG concentrations rather than using direct immunoassay methods, which are inaccurate 6

Common Pitfalls to Avoid

  1. Don't assume the IUD itself interferes with the assay - it doesn't. The device may alter hormone-binding proteins, not test accuracy
  2. Don't use direct free testosterone immunoassays - these are highly inaccurate due to low serum concentrations 5
  3. Don't rely on automated hospital assays for women - systematic differences between assays and excessively broad normal ranges complicate interpretation 5
  4. Don't forget timing - testosterone levels vary by about 25% around the mean during the menstrual cycle and are highest in early morning 5

Bottom Line

The IUD does not affect the accuracy of testosterone measurement, but levonorgestrel-releasing IUDs may modestly decrease SHBG levels. For women with LNG-IUS requiring testosterone assessment, measure both total testosterone and SHBG using validated assays, then calculate free testosterone to account for any SHBG alterations. Copper IUDs have no effect on testosterone or SHBG and require no special testing considerations.

References

Research

Serum SHBG levels during normal menstrual cycle and after insertion of levonorgestrel-releasing IUD.

Advances in contraception : the official journal of the Society for the Advancement of Contraception, 1992

Research

Levonorgestrel-releasing intrauterine system effects on metabolic variables in PCOS.

Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2023

Research

Levels of serum steroid hormones in intrauterine contraceptive device users.

Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 1991

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.